3Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus WorkshopGroup.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polystic ovary syndrome[J].FertilSteril,2004,8l(1):19-25.
4Pritts EA.Treatment of the infertile patient with polycystic ovariansyndrome[J].Obstet Gynecol Surv,2002,57(9):587-597.
5Morin-Papunen L,Vauhkonen I,Koivunen R,et al.MeftorminveYsus et hinvlest radiol-cyproterone acetate in the treatment ofnonobese women with polycystic ovary syndrome:a randomizedstudy[J].J Clin Endocrinol Metab,2003,88(1):148-156.
6Cagnacci A,Paoletti AM,Renzi A.Glucose metabolism andinsulin resistance in women with polycystic ovary syndromeduring therapy with oral contraceptives containing cyproteroneacetate or desogesttel[J].J Clin Endocfinol Metab,2003,88(8):3621-3625.
